Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On study

التفاصيل البيبلوغرافية
العنوان: Six month immunogenicity of COVID-19 mRNA-BNT162b2 vaccine in actively treated cancer patients: updated results of the Vax-On study
المؤلفون: F. Nelli, A. Fabbri, A. Onorato, D. Giannarelli, M.A. Silvestri, G. Pessina, J.R. Giron Berrios, A. Virtuoso, E. Marrucci, M. Schirripa, M. Mazzotta, V. Panichi, P. Cercola, C. Signorelli, M.G. Chilelli, F. Primi, E.M. Ruggeri
المصدر: Annals of Oncology
سنة النشر: 2021
مصطلحات موضوعية: SARS-CoV-2, COVID-19, Hematology, tozinameran, immunogenicity, six-months follow-up, Oncology, Neoplasms, Humans, cancer, RNA, Messenger, anticancer therapy, Letter to the Editor, BNT162 Vaccine
تدمد: 1569-8041
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae882939175e67456906e02dafa64bf7
https://pubmed.ncbi.nlm.nih.gov/34896598
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....ae882939175e67456906e02dafa64bf7
قاعدة البيانات: OpenAIRE